Dermatology

Showing results 41 - 50 of 100

Sorted by most recent

TitleAuthorDate

Novel mixed-method, inclusive protocol involving global key stakeholders, including carers as experts, to co-develop relevant Caregiver-Reported Outcome Domains (CRODs) in skin disease

Carleen Walsh, Gerard Leavey, Marian Mc Laughlin, Amy S Paller, Alan D Irvine, Fiona Browne, Jemima E Mellerio, Anthony Bewley

18 January 2023

Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trial

Rebecca H Haberman, Katrina A MacFarlane, Sydney Catron, Jonathan Samuels, Rebecca B Blank, Michael Toprover, Zakwan Uddin, Jiyuan Hu, Rochelle Castillo, Cinty Gong, Kun Qian, Vincent Piguet, Francisco Tausk, Jensen Yeung, Andrea L NeimannSee the full list of authors

23 December 2022

Prevalence and risk factors of work-related contact dermatitis symptoms among healthcare cleaners during the COVID-19 pandemic in Northwest Ethiopia: a multicentre cross-sectional survey

Amensisa Hailu Tesfaye, Garedew Tadege Engdaw, Fantu Mamo Aragaw, Gebisa Guyasa Kabito

29 November 2022

Study protocol of the BASINEL Study: a pragmatic randomised controlled trial investigating treatment versus no treatment of low-risk basal cell carcinomas in older persons

Laura Van Coile, Evelien Verhaeghe, Katia Ongenae, Lieve Brochez, Isabelle Hoorens

10 November 2022

Prevalence and incidence of hand eczema in healthcare workers: protocol for a systematic review and meta-analysis

Cara Symanzik, Yasemin Topal Yüksel, Maria Oberlander Christensen, Jacob P Thyssen, Christoph Skudlik, Swen Malte John, Richard Brans, Tove Agner

7 October 2022

The Copenhagen Actinic Keratosis Study (COAKS). A decentralised clinical trial to evaluate tolerability, safety and efficacy of daily field-directed topical treatment with cytosolic phospholipase A inhibitor, AVX001, in participants with actinic keratosis: protocol for a randomised controlled phase I/IIa trial

Vinzent Kevin Ortner, Berit Johansen, Kim Kilov, Alejandro Castillo Mondragón, Tore Duvold, Jesper Kihl, Felicity J Ashcroft, Astrid J Feuerherm, Charlotte Pind Laugesen, Maiken Lise Marcker Espersen, Ionela Manole, Ari Pall Isberg, Anders Daniel Andersen, Elin Rakvaag, John R ZibertSee the full list of authors

5 October 2022

Psychological (co)morbidity in patients with psoriasis: the impact of pruritus and anogenital involvement on symptoms of depression and anxiety and on body dysmorphic concerns – a cross-sectional study

Neuza da Silva, Matthias Augustin, Caroline Hilbring, Catharina C Braren-von Stülpnagel, Rachel Sommer

23 September 2022

Oral Janus kinase inhibitors and venous thromboembolic events in atopic dermatitis: protocols for a case–time control study and a nested case-control study based on the French national health insurance (SNDS) cohort

Pauline Berthe, Lucie-Marie Scailteux, Alain Lescoat, Delphine Staumont, Guillaume Coiffier, Pierre Guéret, Alain Dupuy, Emmanuel Oger, Catherine Droitcourt

21 September 2022

Munich atopy prediction study (MAPS): protocol for a prospective birth cohort addressing clinical and molecular risk factors for atopic dermatitis in early childhood

Sarah Preis, Lea Schmidt, Linda Tizek, Maximilian Schielein, Viktoria Lang, Rachela Bleuel, Anna Duswald, Sebastian Sitaru, Annette Blasini, Christine Gasteiger, Lennard Merdha, Zsuzsanna Kurgyis, Bettina Kuschel, Evelyn Hauenstein, Maximilian SanderSee the full list of authors

8 September 2022

Pharmacological interventions for hidradenitis suppurativa: a protocol for systematic review and network meta-analysis of randomised trials and non-randomised studies

Naritthorn Aroonsakul, Phichayut Phinyo, Lalita Lumkul, Nutcha Jarupanich, Jacek Szepietowski, Mati Chuamanochan, Surapon Nochaiwong

8 September 2022

Prev 1 2 3 456 7 8 9 10 Next